| Primary |
| Drug Use For Unknown Indication |
38.5% |
| Product Used For Unknown Indication |
20.9% |
| Epilepsy |
5.5% |
| Hiv Infection |
5.5% |
| Psychotic Disorder |
4.4% |
| Hypomania |
3.3% |
| Bipolar Disorder |
2.2% |
| Constipation |
2.2% |
| Depression |
2.2% |
| Diarrhoea |
2.2% |
| Oral Candidiasis |
2.2% |
| Schizophrenia |
2.2% |
| Antifungal Prophylaxis |
1.1% |
| Anxiolytic Therapy |
1.1% |
| Headache |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Mood Swings |
1.1% |
| Nausea |
1.1% |
| Pain In Extremity |
1.1% |
| Prophylaxis |
1.1% |
|
| Convulsion |
12.5% |
| Pneumonia |
12.5% |
| Thrombocytopenia |
12.5% |
| Toxicity To Various Agents |
12.5% |
| Vomiting |
12.5% |
| Hepatic Cirrhosis |
6.3% |
| Oedema Peripheral |
6.3% |
| Paraesthesia |
6.3% |
| Product Substitution Issue |
6.3% |
| Weight Increased |
6.3% |
| White Blood Cell Count Decreased |
6.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
15.9% |
| Product Used For Unknown Indication |
13.4% |
| Hiv Infection |
12.2% |
| Depression |
7.3% |
| Hypomania |
7.3% |
| Psychotic Disorder |
7.3% |
| Constipation |
4.9% |
| Diarrhoea |
4.9% |
| Oral Candidiasis |
4.9% |
| Antifungal Prophylaxis |
2.4% |
| Headache |
2.4% |
| Nausea |
2.4% |
| Pain In Extremity |
2.4% |
| Prophylaxis |
2.4% |
| Schizoaffective Disorder |
2.4% |
| Vitamin Supplementation |
2.4% |
| Epilepsy |
1.2% |
| Glioblastoma |
1.2% |
| Psoriasis |
1.2% |
| Relapsing-remitting Multiple Sclerosis |
1.2% |
|
| Vomiting |
27.3% |
| Somnolence |
18.2% |
| White Blood Cell Count Decreased |
18.2% |
| Convulsion |
9.1% |
| Oedema Peripheral |
9.1% |
| Pancytopenia |
9.1% |
| Toxicity To Various Agents |
9.1% |
|
| Concomitant |
| Schizophrenia |
21.0% |
| Bipolar Disorder |
17.3% |
| Drug Use For Unknown Indication |
9.5% |
| Product Used For Unknown Indication |
7.5% |
| Schizoaffective Disorder |
6.1% |
| Epilepsy |
5.8% |
| Rheumatoid Arthritis |
4.7% |
| Diabetes Mellitus |
3.7% |
| Major Depression |
3.1% |
| Convulsion |
2.7% |
| Psychotic Disorder |
2.7% |
| Bipolar I Disorder |
2.4% |
| Osteoporosis |
2.4% |
| Schizophrenia, Paranoid Type |
2.4% |
| Gout |
2.0% |
| Ataxia |
1.4% |
| Depression |
1.4% |
| Headache |
1.4% |
| Multiple Sclerosis |
1.4% |
| Neutropenia |
1.4% |
|
| White Blood Cell Count Decreased |
19.4% |
| Death |
8.6% |
| Neuroleptic Malignant Syndrome |
6.5% |
| Vomiting |
6.5% |
| Weight Increased |
5.4% |
| White Blood Cell Count Increased |
5.4% |
| Renal Failure Acute |
4.3% |
| Somnolence |
4.3% |
| Unresponsive To Stimuli |
4.3% |
| Wrong Drug Administered |
4.3% |
| Chromaturia |
3.2% |
| Diabetes Mellitus |
3.2% |
| Myalgia |
3.2% |
| Pain |
3.2% |
| Rhabdomyolysis |
3.2% |
| Urinary Retention |
3.2% |
| Volvulus |
3.2% |
| Weight Decreased |
3.2% |
| Wound |
3.2% |
| Asthenia |
2.2% |
|
| Interacting |
| Epilepsy |
50.0% |
| Pain |
50.0% |
|
| Drug Interaction |
50.0% |
| Vomiting |
50.0% |
|
